Raed Suleiman, MD
Pulmonary Disease · Gastonia, NCNPI 1730657115
Payments from drug & device makers
Across 439 payments — averaging $443.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$189K
- GSK$1K
- Olympus Corporation Of The Americas$632
- Boehringer Ingelheim$603
- Insmed, Inc.$409
- Actelion Pharmaceuticals US, Inc.$276
- plus $3K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 236 | $189,011 |
| GSK | 44 | $1,093 |
| Olympus Corporation Of The Americas | 2 | $632 |
| Boehringer Ingelheim | 21 | $603 |
| Insmed, Inc. | 16 | $409 |
| Actelion Pharmaceuticals US, Inc. | 11 | $276 |
| Grifols USA, LLC | 14 | $257 |
| Electromed, Inc. | 17 | $247 |
| Jazz Pharmaceuticals Inc. | 2 | $178 |
| Amgen | 4 | $172 |
| Verona Pharma, Inc. | 4 | $170 |
| Regeneron Healthcare Solutions, Inc. | 6 | $167 |
| Sanofi | 6 | $161 |
| Mylan Specialty L.p. | 8 | $161 |
| Genentech, Inc. | 1 | $129 |
| Merck | 6 | $121 |
| Inspire Medical Systems, Inc. | 2 | $112 |
| United Therapeutics Corporation | 4 | $90 |
| Pulmonx Corporation | 2 | $85 |
| Harmony Biosciences LLC | 4 | $84 |
| Novo Nordisk | 1 | $73 |
| Pfizer | 3 | $68 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $63 |
| Nabriva Therapeutics, PLC | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Mallinckrodt Hospital Products Inc. | 2 | $39 |
| Philips North America LLC | 3 | $39 |
| CSL Behring | 1 | $34 |
| Advanced Respiratory, Inc | 2 | $31 |
| Baxter Healthcare | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Viatris Specialty LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $14 |
| AbbVie | 1 | $14 |
| Resmed Corp | 1 | $11 |
How this compares
$194,778 in reported general payments places this provider in the 90th percentile of 393 pulmonary disease providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Gastonia
- Anup BanerjeeGastonia$2.1M
- Mikell JarrattGastonia$1.7M
- Emeka EziriGastonia$252K
- Selwyn SpangenthalCharlotte$7M
- Thomas SternHuntersville$5.2M
- Laurie SnyderDurham$3.8M
- Scott PalmerDurham$3.8M
- Michael PritchettPinehurst$2.2M
- Hubert FordChapel Hill$2M
- Murali RamaswamyGreensboro$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.